Abstract

Objectives Rheumatoid arthritis (RA) is associated with increased cardiovascular mortality. Proposed mechanisms include coronary microvascular dysfunction due to immune dysregulation and systemic inflammation. First pass myocardial perfusion CMR allows quantification of myocardial blood flow (MBF) and myocardial perfusion reserve (MPR). In the absence of coronary artery disease (CAD), reduced MPR represents coronary microvascular dysfunction. We hypothesised MPR would be reduced in RA and that abnormalities in left ventricular (LV) deformation would be evident in RA, as LV mass has been reported to be reduced in established disease. Methods Twelve patients with newly diagnosed, treatment naive RA and 12 healthy volunteers (HV) underwent CMR at 3.0T (Phillips Achieva TX). Both groups had no history of CAD. Dual bolus resting and stress perfusion imaging was performed (0.1mmol/kg Gadolinium DTPA) and MBF estimated for the mid ventricular slice using Fermi constrained convolution (PMI v 0.4 [Sourbron, 2009]). Left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) by feature tracking were calculated using bSSFP images (CVI 42 , Circle Cardiovascular Imaging, Calgary, Canada). Results Mean age of RA patients was 48 ± 16 and mean age of HV 47 ± 14. Of the RA patients, 4 were male and 8 female. Of the HV, 2 were male and 10 female. Mean MPR values were 1.98 ± 0.79 and 1.99 ± 0.72 (P = 0.88) for RA and HV respectively (Figure 1). Mean values for LVEF were 63 ± 4 and 62 ± 4% (P = 0.48) respectively for RA patients and HV. Mean values for GLS were −20.2 and −21 ± 0.4 (P = 0.396) for RA and HV respectively. Conclusion These findings suggest treatment naive RA patients have no detectable abnormalities on perfusion CMR. Therefore, whilst present in established RA, coronary microvascular dysfunction may not yet have developed in early RA. No abnormalities of LV systolic function were evident and may be a later manifestation of RA.

Highlights

  • Left ventricular end-diastolic filling pressure (LVEDP) is an invasive measure of left ventricular (LV) function obtained at cardiac catheterisation (CC) that predicts prognosis and guides therapeutic strategy

  • We hypothesised myocardial perfusion reserve (MPR) would be reduced in Rheumatoid arthritis (RA) and that abnormalities in left ventricular (LV) deformation would be evident in RA, as LV mass has been reported to be reduced in established disease

  • Mean values for Global longitudinal strain (GLS) were À20.2 and À21 ± 0.4 (P = 0.396) for RA and healthy volunteers (HV) respectively. These findings suggest treatment naïve RA patients have no detectable abnormalities on perfusion CMR

Read more

Summary

Introduction

Left ventricular end-diastolic filling pressure (LVEDP) is an invasive measure of LV function obtained at cardiac catheterisation (CC) that predicts prognosis and guides therapeutic strategy. Results Patients were divided into 2 groups: low EDP (13 ± 2.4mmHg) and high EDP (36.1 ± 3.4mmHg) (p < 0.01). Both groups were evenly matched for baseline demographics (Table 1). In multivariable analysis of demographics and CMR parameters PALS was the only determinant of LVEDP independent of other factors (Beta À0.93 p = 0.01). Conclusion LA function (PALS) as measured by FT-CMR is independently associated with LVEDP and may have a role in predicting LV filling pressures via a routine CMR protocol

Objectives
Methods
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.